Convergent R.N.R. Overview
Convergent Radiotherapy and Radiosurgery is a medical start-up developing a new X-ray-focusing technology called MercyBeam. The companys patented technology uses a standard imaging X-ray source to form a converging beam into a volume of treatment, rather than the standard diverging one. This development is designed to render radiotherapy treatment more accurate and safe and to spare healthy organs and cells. MercyBeam introduces a lens that collects most of the X-rays emanating divergently out of any standard X-ray tube and converges themtoward the tumors location. The lens simultaneously removes low-energy photons that would be absorbed by the patients skin. The convergence increases the therapeutic dose delivered at the tumor location, while the organs in the vicinity of the tumor receive a very low dose or none at all. The converging technology enables the use of photon-energy X-rays 100 times lower than those used by current systems based on linear accelerators.
Cumulative Funding Raised Over Time ($)
$700K
$3.7MDec 2017
Latest News
growth-positive
MD Anderson and Convergent R.N.R. Ltd. Establish Alliance to Further Develop New Radiation Technology with Potentially Fewer Side Effects
The University of Texas MD Anderson Cancer Center and Convergent R.N.R. Ltd. (CRnR) have announced a collaboration to develop new radiation technology aimed at reducing side effects of standard radiation. MD Anderson will work on enhancing and implementing CRnRs X-ray lens system called Mercy Beam™ to deliver tumor-killing radiation while limiting radiation to healthy organs. The study will focus on the systems use in treating head and neck, pediatric, and small tumors in various cancers. The collaboration will benefit CRnR by establishing it as a leader in treating small tumors and potentially speeding up development through preclinical and clinical trials. CRnR will develop an MLC-like collimator for MD Andersons assessment. MD Anderson will receive payments based on market capitalization, milestones toward FDA approval, and royalties for cancer treatments.
PartnersInvestment
growth-positive
Israeli Engineer Creates Lens to Reduce Risks of Radiation Therapy...
An Israeli industrial engineer has developed a special lens called MercyBeam to improve radiation therapy, particularly for children. The lens collects three-dimensional X-rays and converges them directly onto a tumor, increasing the dosage in tumor cells while minimizing radiation to healthy tissue. The technology allows for the use of lower-energy X-rays, reducing the risks of radiation therapy in children. Convergent R.N.R. collaborated with top hospitals during development and received positive feedback. MercyBeam is expected to be more affordable than current systems, with a cost between $700,000 and $1 million. The company is seeking funding to build a prototype after receiving a grant of $700,000 from the Office of the Chief Scientist.
Customers
growth-positive
Radiation therapy is about to get much kinder
Israeli company Convergent RNR has developed MercyBeam, a patented lens to improve radiation therapy for patients of all ages. The lens collects three-dimensional X-rays and converges them towards the tumor, increasing the therapeutic dose while minimizing exposure to surrounding tissue. MercyBeam is smaller, lighter, and less expensive than current radiation therapy systems, making it more accessible for clinics and hospitals. The company is collaborating with top hospitals and is in discussions with others to install the system. Convergent RNR is currently raising funds to build a prototype through conventional fundraising and a twist on crowdfunding called Contribute-Match-Donate. The company aims to reduce the price of the lens by growing the metal crystals themselves. Convergent RNR is headquartered in Tirat Carmel, Israel.
InvestmentExpand
N/A
Welcome saferadiotherapy.com - BlueHost.com
The article is a generic web hosting advertisement for Bluehost.com.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $3.7M |
| Last funding | $3M |
| Stage | Mature |
| Rounds | 2 |
| Investors | 1 |
Team Members
4
Employees: 11-50
Web & Social Links
| Website | convergent-rnr.com |
Locations
Andrei Sakharov St 9, Haifa, Israel
Photos & Videos
2 item(s)
Convergent R.N.R. Business
Business models
B2B
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsTarget Customer
Healthcare & Life SciencesHealthcarePatientsProvidersCore Technology
Simulation & ImagingTags (17)
medical-technologiescanceroncologyx-raylensesradiologybabiesmedical-deviceshealthcare-providersnon-invasivehospitalschildrenpatientsimagingoptronicstreatmentsbioconvergenceConvergent R.N.R. Financials
$3.7M
Total funding
Undisclosed
Capital raised
$3M
Last funding
Mature
Funding stage
2
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
$700K
$3.7MDec 2017
Private Equity Funding
Undisclosed Round
Dec 2017
$3M
Seed
$700K
Office of the Chief Scientist
Convergent R.N.R. Lifecycle
Cumulative Funding Raised Over Time
$700K
$3.7MDec 2017
All Events
Undisclosed Round
Dec 2017
$3M
Seed
$700K
Office of the Chief Scientist
Convergent R.N.R. News
4 articles
growth-positive
MD Anderson and Convergent R.N.R. Ltd. Establish Alliance to Further Develop New Radiation Technology with Potentially Fewer Side Effects
The University of Texas MD Anderson Cancer Center and Convergent R.N.R. Ltd. (CRnR) have announced a collaboration to develop new radiation technology aimed at reducing side effects of standard radiation. MD Anderson will work on enhancing and implementing CRnRs X-ray lens system called Mercy Beam™ to deliver tumor-killing radiation while limiting radiation to healthy organs. The study will focus on the systems use in treating head and neck, pediatric, and small tumors in various cancers. The collaboration will benefit CRnR by establishing it as a leader in treating small tumors and potentially speeding up development through preclinical and clinical trials. CRnR will develop an MLC-like collimator for MD Andersons assessment. MD Anderson will receive payments based on market capitalization, milestones toward FDA approval, and royalties for cancer treatments.
PartnersInvestment
growth-positive
Israeli Engineer Creates Lens to Reduce Risks of Radiation Therapy...
An Israeli industrial engineer has developed a special lens called MercyBeam to improve radiation therapy, particularly for children. The lens collects three-dimensional X-rays and converges them directly onto a tumor, increasing the dosage in tumor cells while minimizing radiation to healthy tissue. The technology allows for the use of lower-energy X-rays, reducing the risks of radiation therapy in children. Convergent R.N.R. collaborated with top hospitals during development and received positive feedback. MercyBeam is expected to be more affordable than current systems, with a cost between $700,000 and $1 million. The company is seeking funding to build a prototype after receiving a grant of $700,000 from the Office of the Chief Scientist.
Customers
growth-positive
Radiation therapy is about to get much kinder
Israeli company Convergent RNR has developed MercyBeam, a patented lens to improve radiation therapy for patients of all ages. The lens collects three-dimensional X-rays and converges them towards the tumor, increasing the therapeutic dose while minimizing exposure to surrounding tissue. MercyBeam is smaller, lighter, and less expensive than current radiation therapy systems, making it more accessible for clinics and hospitals. The company is collaborating with top hospitals and is in discussions with others to install the system. Convergent RNR is currently raising funds to build a prototype through conventional fundraising and a twist on crowdfunding called Contribute-Match-Donate. The company aims to reduce the price of the lens by growing the metal crystals themselves. Convergent RNR is headquartered in Tirat Carmel, Israel.
InvestmentExpand
N/A
Welcome saferadiotherapy.com - BlueHost.com
The article is a generic web hosting advertisement for Bluehost.com.
Convergent R.N.R. Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 17 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
Convergent R.N.R. Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 92/100 |
| Missing | not claimed |
| BI Verification | Sharon Shapira |
| Registrar ID | 514498443 |
| Crunchbase | convergent-rnr |
| Phone | +97237255961 |
| Last updater | Orli Wollner |
| Updater email | orlushka@gmail.com |
| Last update | 2020-10-13T00:00:00.000Z |
| Created | 2014-12-15T00:00:00.000Z |
| Claimed | Yes |